OncoCyte Corporation (OCX): Price and Financial Metrics
OncoCyte Corporation (OCX)
Today's Latest Price: $5.85 USD
Updated Jan 25 6:40pm
Add OCX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 64 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
OCX Stock Summary
- OCX's price/sales ratio is 448.34; that's higher than the P/S ratio of 98.48% of US stocks.
- With a year-over-year growth in debt of 591.49%, OncoCyte Corp's debt growth rate surpasses 96.93% of about US stocks.
- As for revenue growth, note that OCX's revenue has grown 4,362.5% over the past 12 months; that beats the revenue growth of 99.73% of US companies in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to OncoCyte Corp are MOTS, FUV, ITCI, IPWR, and TRVN.
- Visit OCX's SEC page to see the company's official filings. To visit the company's web site, go to www.oncocyte.com.
OCX Stock Price Chart Interactive Chart >
OCX Price/Volume Stats
| Current price | $5.85 | 52-week high | $6.13 |
| Prev. close | $4.76 | 52-week low | $1.15 |
| Day low | $5.26 | Volume | 4,357,100 |
| Day high | $6.13 | Avg. volume | 1,765,060 |
| 50-day MA | $2.52 | Dividend yield | N/A |
| 200-day MA | $2.06 | Market Cap | 393.42M |
OncoCyte Corporation (OCX) Company Bio
OncoCyte Corporation focuses on developing diagnostic tests for the detection of breast, bladder, and lung cancers. The company was founded in 2009 and is based in Alameda, California.
Loading social stream, please wait...